Brookstone Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Brookstone Capital Management's EXAS Position: Q1 2026 in Review
Brookstone Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10,248 shares — an estimated $1.04M sold.
Brookstone Capital Management first reported a position in EXAS in Q2 2021 and held it in 11 quarters. The position peaked at $1.04M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Brookstone Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Brookstone Capital Management sold 10,248 Exact Sciences shares in Q1 2026, an estimated $1.04M.
- Brookstone Capital Management first reported a position in Exact Sciences in Q2 2021 and held it in 11 quarters.
- Brookstone Capital Management's Exact Sciences position peaked at $1.04M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Brookstone Capital Management's 13F filing for Q1 2026, filed 16 Apr 2026.